Alnylam Pharmaceuticals · 1 day ago
Associate Director, Ethics and Compliance
Cambridge, MA
Full-time
Hybrid
Lead/Staff, Director/Executive
$162K/yr - $220K/yr
8+ years expAlnylam Pharmaceuticals is a leader in RNAi therapeutics, and they are seeking an Associate Director, Ethics and Compliance. This role involves managing global investigations and enterprise risk management, enhancing the internal investigations program, and collaborating with various stakeholders to ensure compliance and risk mitigation.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Conducting and assisting on investigations into reported ethics and compliance concerns, or any allegations of misconduct, as required
Assisting with the design and implementation of enhancements to Alnylam’s speak up program and culture, including drafting of policies and procedures, and development and implementation of relevant trainings and resources in accordance with applicable global laws and practices
Drafting concise and accurate investigation reports and presentations, and providing an overview of the key issues, findings, trends, and outcomes related to investigations to senior management and business leaders
Presenting updates on investigations, including investigation trends and remediation, to the Chief Ethics & Compliance Officer (CECO) and other cross-functional senior leaders at various forums (e.g., regular updates to Legal, Human Resources, Internal Audit, and Compliance Committees, as necessary)
Monitoring Alnylam’s global database of reported ethics and compliance matters, the Alnylam Helpline, and other global reporting channels for the intake of complaints
Managing Alnylam’s case management software system, including updating matter information in the system and working with vendor on system enhancements and updates, as necessary
Working closely and collaboratively with key internal stakeholders, including Human Resources, People Relations, and Legal on matters, including with respect to the remediation of matters and recommendations for appropriate disciplinary action
Supporting the Company’s global ERM program and related processes by conducting enterprise risk assessments and risk mitigation planning, partnering with cross-functional enterprise leaders, including Finance, Internal Audit, IT, Procurement, and Legal, among others
Preparing enterprise risk reports and other presentations on the ERM program and annual risk assessments for key stakeholders
Overseeing the Company’s risk management software system, including by managing risk and risk assessment information in the system, and working with the vendor to make system enhancements as necessary and to align with the ERM program
Helping manage ERM oversight committee meetings, and coordinating with key stakeholders to continue advancing Alnylam’s ERM program
Assisting with the design and implementation of enhancements to Alnylam’s ERM program, including drafting of governance materials and development of related processes and systems
Qualification
Required
A Bachelor's degree, or equivalent combination of education and work-related experience is required
8+ years' related experience, including law firm and/or in-house experience leading and managing global ethics and compliance investigations in the pharmaceutical or life sciences industry, and experience managing enterprise risk management programs
Demonstrated ability to collaborate cross-functionally with U.S. and ex-U.S. personnel
Comprehensive knowledge of laws and regulations applicable to global pharmaceutical companies, including, U.S. healthcare fraud and abuse laws, anti-corruption laws, such as the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act (2010), U.S. fraud and abuse and false claims laws, and relevant industry codes on interactions with healthcare professionals
Experience working with case management and enterprise risk management software systems
Strong written and verbal communication skills, with fluency in written and spoken English required
Possess an innovative mindset and have an ability to take a practical, solutions-oriented approach
Ability to work collaboratively in a team environment, with a strong focus on partnerships
Ability to manage multiple tasks simultaneously, to work independently and manage discrete areas of responsibility, and to flourish in a fast-paced environment
Ability to thrive in a proactive ethical culture in which compliance and business objectives are mutually reinforcing
Excellent organizational and time management skills
Strong motivation and ability to champion a comprehensive compliance program that is integrated with Alnylam's business and culture
Strong commitment to ethics and integrity in all aspects of their work
Travel will be required on occasion to Alnylam offices in the U.S. and overseas
Preferred
A law degree is strongly preferred
Benefits
Comprehensive benefits including medical, dental, and vision coverage
Life and disability insurance
A lifestyle reimbursement program
Flexible spending and health savings accounts
A 401(k) with a generous company match
Paid time off
Wellness days
Holidays
Two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
1001-5000 employees
H1B Sponsorship
Alnylam Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (18)
2021 (19)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Leadership Team
Yvonne Greenstreet
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Recent News
2025-12-22
2025-12-20
Company data provided by crunchbase